Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval
Lilly(US:LLY) Reuters·2026-03-02 20:58Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake [Purchase Licensing Rights, opens new tab]- Companies[Eli Lilly and Co]FollowMarch 2 (Reuters) - Eli Lilly [(LLY.N), opens new tab] CFO Lucas Montarce said on Monday it is pr ...